# A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation

> **NCT01339468** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 100 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Advagraf
- **DRUG:** Prograf
- **DRUG:** Prograf

## Key facts

- **NCT ID:** NCT01339468
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-27
- **Primary completion:** 2014-05-27
- **Final completion:** 2014-05-27
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01339468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01339468, "A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01339468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*